Publicacions
-
Zarei M, Barroso E, Palomer FX, Escolà-Gil JC, Cedó L, Wahli W and Vazquez M.
Pharmacological PPARß/d activation upregulates VLDLR in hepatocytes.
Clinica e Investigacion en Arteriosclerosis . 31(3): 111-118. Nº de cites: 9
-
Botteri G, Salvadó L, Gumà A, Lee Hamilton D, Meakin PJ, Montagut G, Ashford MLJ, Ceperuelo-Mallafré V, Fernández-Veledo S, Vendrell J, Calderón-Dominguez M, Serra D, Herrero L, Pizarro J, Barroso E, Palomer FX and Vazquez M.
The BACE1 product sAPPß induces ER stress and inflammation and impairs insulin signaling.
METABOLISM-CLINICAL AND EXPERIMENTAL . 85: 59-75. Nº de cites: 24
-
Palomer FX, Pizarro J and Vazquez M.
Emerging Actors in Diabetic Cardiomyopathy: Heartbreaker Biomarkers or Therapeutic Targets?
TRENDS IN PHARMACOLOGICAL SCIENCES . 39(5): 452-467. Nº de cites: 51
-
Palomer FX, Barroso E, Pizarro J, Peña L, Botteri G, Zarei M, Aguilar D, Montori M and Vazquez M.
PPARß/d: A Key Therapeutic Target in Metabolic Disorders.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 19(3): . Nº de cites: 58
-
Palomer FX, Pizarro J, Barroso E and Vazquez M.
Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes Mellitus.
TRENDS IN ENDOCRINOLOGY AND METABOLISM . 29(3): 178-190. Nº de cites: 326
-
Zarei M, Barroso E, Palomer FX, Dai J, Rada P, Quesada T, Escolà-Gil JC, Cedó L, Zali MR, Molaei M, Dabiri R, Vázquez S, Pujol E, Valverde ÁM, Villarroya-Gombau F, Liu Y, Wahli W and Vazquez M.
Hepatic regulation of VLDL receptor by PPARß/d and FGF21 modulates non-alcoholic fatty liver disease.
molecular metabolism . 8: 117-131. Nº de cites: 63
-
Botteri G, Montori M, Gumà A, Pizarro J, Cedó L, Escolà-Gil JC, Li D, Barroso E, Palomer FX, Kohan AB and Vazquez M.
VLDL and apolipoprotein CIII induce ER stress and inflammation and attenuate insulin signalling via Toll-like receptor 2 in mouse skeletal muscle cells.
Diabetologia . 60(11): 2262-2273. Nº de cites: 23
-
Palomer FX, Barroso E, Zarei M, Botteri G and Vazquez M.
PPAR beta/delta and lipid metabolism in the heart
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS . 1861(10): 1569-1578. Nº de cites: 32
-
Garcia-Ramírez M, Hernández C, Palomer FX, Vazquez M and Simó R.
Fenofibrate prevents the disruption of the outer blood retinal barrier through downregulation of NF-?B activity.
ACTA DIABETOL . 53(1): 109-118. Nº de cites: 26
-
Palomer FX, Capdevila-Busquets E, Botteri G, Davidson MM, Rodríguez C, Martínez-González J, Vidal F, Barroso E, Chan TO, Feldman AM and Vazquez M.
miR-146a targets Fos expression in human cardiac cells
DISEASE MODELS & MECHANISMS . 8(9): 1081-1091. Nº de cites: 33